Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Vesiculobullous disease
- Vesiculobullous disease: classification
- Hereditary diseases
- Allergy
- Infections
- Vesiculobullous lesions
- Immunologically-mediated diseases (1)
- Immunologically-mediated diseases (2)
- Immunologically-mediated diseases (3)
- Immunologically-mediated diseases (4)
- Frequent subepithelial blister formation (1)
- Frequent subepithelial blister formation (2)
- Mucous membrane pemphigoid (1)
- Antigens involved in vesiculobullous diseases (1)
- Mucous membrane pemphigoid: illustration
- Mucous membrane pemphigoid: clinical features
- Mucous membrane pemphigoid: images (1)
- Mucous membrane pemphigoid: images (2)
- Mucous membrane pemphigoid: images (3)
- Mucous membrane pemphigoid: images (4)
- Mucous membrane pemphigoid: histopathology (1)
- Mucous membrane pemphigoid: histopathology (2)
- Mucous membrane pemphigoid: histopathology (3)
- Immunofluorescence (IF)
- Mucous membrane pemphigoid: IF
- Mucous membrane pemphigoid: treatment (1)
- Mucous membrane pemphigoid: treatment (2)
- Mucous membrane pemphigoid: treatment (3)
- Bullous pemphigoid
- Bullous pemphigoid: clinical features (1)
- Bullous pemphigoid: clinical features (2)
- Bullous pemphigoid: image (1)
- Bullous pemphigoid: image (2)
- Bullous pemphigoid: image (3)
- Bullous pemphigoid: histopathology and IF
- Bullous pemphigoid: histopathology image
- Bullous pemphigoid: treatment
- Bullous pemphigoid: images
- Dermatitis herpetiformis
- Dermatitis herpetiformis: clinical features
- Dermatitis herpetiformis: images
- Dermatitis herpetiformis: histopathology and IF
- Dermatitis herpetiformis: treatment
- Linear IgA disease
- Linear IgA disease: histopathology and IF
- Epidermolysis bullosa acquisita
- Antigens involved in vesiculobullous diseases (2)
- Epidermolysis bullosa acquisita: images
- Epidermolysis bullosa acquisita: treatment
- Angina bullosa hemorrhagica
- Occasional subepithelial blister formation diseases
Topics Covered
- Vesiculbullous diseases: definition and causes
- Hereditary diseases
- Allergy
- Infections
- Immunologically-mediated diseases
- Diseases showing frequent subepithelial blister formation
- Mucous membrane pemphigoid
- Bullous pemphigoid
- Dermatitis herpetiformis
- Linear IgA disease
- Epidermolysis bullosa acquisita
- Angina bullosa hemorrhagica
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Nikitakis, N. (2017, April 30). Soreness and ulcers 3: due to vesiculobullous disease 1 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 14, 2024, from https://doi.org/10.69645/RAPM7498.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Nikolaos Nikitakis has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Soreness and ulcers 3: due to vesiculobullous disease 1
Published on April 30, 2017
37 min
Transcript
Please wait while the transcript is being prepared...
0:00
Hello.
This talk is about soreness and ulcers
due to vesiculobullous disease.
And this is Dr. Nikolaos Nikitakis
from the University of Athens.
0:14
Today, we will talk about
vesiculobullous diseases
and under this term
we can classify any disease
that may affect the oral mucosa
with a clinical presentation
of a vesicle or a bulla.
Both these terms
refer to a fluid-filled cavity
which is either small,
less than 5 millimeters,
this is a vesicle, or larger than
5 millimeter, and this is bulla.
In the oral mucosa these lesions
are the vesiculobullous lesions
are short-lived, in other words
they do not last long,
they rupture easily and as a result
what we will see most often
will be erosions or ulcers.
We may see impact blisters,
vesicles, or bullae,
or we may not see at all impacted blisters,
instead we see the result
of the breaking down,
which is the erosions and ulcers
that they leave behind.
1:19
The vesiculobullous diseases
affecting the oral mucosa
can be classified in various categories
according to their etiology and pathogenesis.
The main categories
are the immunologically-mediated diseases,
the hereditary diseases, the allergies,
and the infections.
For this presentation,
we will focus
on the immunologically-mediated diseases.
But let's briefly see
the other three categories.